Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
PHG 
Koninklijke Philips NV ADR (PHG)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/29/2025: PHG (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
3 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $32.52
1 Year Target Price $32.52
| 1 | Strong Buy |
| 1 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -3.22% | Avg. Invested days 36 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/29/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 25.78B USD | Price to earnings Ratio 142.68 | 1Y Target Price 32.52 |
Price to earnings Ratio 142.68 | 1Y Target Price 32.52 | ||
Volume (30-day avg) 3 | Beta 0.91 | 52 Weeks Range 20.65 - 29.54 | Updated Date 12/29/2025 |
52 Weeks Range 20.65 - 29.54 | Updated Date 12/29/2025 | ||
Dividends yield (FY) 3.57% | Basic EPS (TTM) 0.19 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.93% | Operating Margin (TTM) 7.65% |
Management Effectiveness
Return on Assets (TTM) 2.37% | Return on Equity (TTM) 1.54% |
Valuation
Trailing PE 142.68 | Forward PE 14.97 | Enterprise Value 33139667520 | Price to Sales(TTM) 1.45 |
Enterprise Value 33139667520 | Price to Sales(TTM) 1.45 | ||
Enterprise Value to Revenue 1.58 | Enterprise Value to EBITDA 11.55 | Shares Outstanding 950979000 | Shares Floating 768029660 |
Shares Outstanding 950979000 | Shares Floating 768029660 | ||
Percent Insiders - | Percent Institutions 5.33 |
Upturn AI SWOT
Koninklijke Philips NV ADR
Company Overview
History and Background
Koninklijke Philips N.V. (Royal Philips) was founded in 1891 in Eindhoven, Netherlands, by Gerard Philips. Initially a manufacturer of incandescent lamps, Philips diversified over the decades into various electronics and healthcare sectors. Key milestones include the invention of the compact cassette tape in 1963, the development of CD technology with Sony in the 1970s, and a strategic pivot towards healthcare technology starting in the late 2000s. The company now operates as Philips N.V., with its American Depositary Receipts (ADRs) trading on the US stock market.
Core Business Areas
- Personal Health: This segment focuses on consumer health and well-being products, including electric toothbrushes, shavers, epilators, and air purifiers. The goal is to empower consumers to take better care of their health.
- Connected Care: This segment provides integrated solutions for healthcare professionals and patients, encompassing patient monitoring, telehealth, sleep and respiratory care, and cardiac care. It aims to improve patient outcomes and reduce healthcare costs.
- Diagnostic Imaging: This is a significant segment offering advanced medical imaging systems such as MRI, CT scanners, X-ray systems, and ultrasound equipment for diagnosis and treatment planning.
- Image-Guided Therapy: This segment focuses on interventional imaging systems and solutions used in minimally invasive procedures for cardiology, neurovascular, and oncology.
Leadership and Structure
Koninklijke Philips N.V. is a publicly traded company with a Supervisory Board and a Management Board. The Management Board, led by the CEO, is responsible for the day-to-day operations and strategy. Key executives typically include the CEO, CFO, and heads of major business segments.
Top Products and Market Share
Key Offerings
- Description: Philips Sonicare is a leading brand of electric toothbrushes known for their sonic technology. Competitors include Oral-B (Procter & Gamble), Colgate, and various smaller electric toothbrush brands. Market share data is proprietary but Sonicare is a dominant player in the premium electric toothbrush segment.
- Product Name 1: Sonicare Electric Toothbrushes
- Description: Philips offers a range of CPAP machines and accessories for treating sleep apnea and other respiratory conditions. Competitors include ResMed, Fisher & Paykel Healthcare, and others. Philips has faced significant product recalls in this area impacting market share and reputation.
- Product Name 2: DreamStation Sleep and Respiratory Care Devices
- Description: Philips' Ingenia line of MRI scanners are advanced diagnostic imaging tools used in hospitals and imaging centers. Key competitors include Siemens Healthineers, GE Healthcare, and Canon Medical Systems. Philips holds a significant share in the global MRI market.
- Product Name 3: Ingenia MRI Systems
- Description: These systems are used in interventional suites for procedures like angioplasty and stenting. Competitors include Siemens Healthineers and GE Healthcare. This segment is crucial for Philips' healthcare solutions portfolio.
- Product Name 4: Azurion Image-Guided Therapy Systems
Market Dynamics
Industry Overview
Philips operates in the global healthcare technology and consumer health markets. The healthcare technology sector is characterized by strong demand driven by aging populations, increasing chronic diseases, and advancements in medical technology. It's a highly regulated and competitive industry with a significant focus on innovation and patient outcomes. The consumer health market is driven by increasing consumer awareness of well-being and preventative care.
Positioning
Philips is positioned as a leader in health technology, with a strong emphasis on connected care and diagnostic solutions. Its competitive advantages include a broad product portfolio, a global presence, strong brand recognition in both consumer and professional healthcare markets, and significant R&D capabilities. However, recent product recalls have presented challenges to its market position and reputation.
Total Addressable Market (TAM)
The global healthcare market is valued in trillions of dollars. Philips is positioned to capture a significant portion of the TAM within its specific segments, including diagnostic imaging, image-guided therapy, patient monitoring, and personal health. The company's strategic focus on integrated solutions aims to address a growing demand for connected healthcare.
Upturn SWOT Analysis
Strengths
- Strong brand recognition and reputation in healthcare and consumer electronics.
- Diversified product portfolio across multiple healthcare segments and consumer health.
- Extensive global distribution network and established customer relationships.
- Significant investment in research and development, driving innovation.
- Focus on connected care and integrated solutions aligns with market trends.
Weaknesses
- Past product recalls, particularly in sleep and respiratory care, have impacted revenue and trust.
- High dependence on specific product lines and segments.
- Intense competition from established players and emerging technologies.
- Potential for supply chain disruptions impacting production and delivery.
- Integration challenges for acquisitions and ongoing restructuring efforts.
Opportunities
- Growing demand for personalized and preventative healthcare solutions.
- Expansion in emerging markets with increasing healthcare spending.
- Leveraging AI and data analytics for enhanced diagnostic and treatment capabilities.
- Strategic partnerships and collaborations to expand service offerings.
- Continued growth in the digital health and telehealth sectors.
Threats
- Intensifying competition and price pressures.
- Stringent regulatory changes and compliance costs.
- Geopolitical instability and economic downturns affecting global demand.
- Cybersecurity risks and data privacy concerns in connected health.
- Rapid technological advancements by competitors requiring continuous innovation.
Competitors and Market Share
Key Competitors
- Siemens Healthineers AG (SIEGY)
- GE HealthCare Technologies Inc. (GEHC)
- ResMed Inc. (RMD)
- Koninklijke Philips NV ADR stock symbol is PHG.
- Medtronic plc (MDT)
Competitive Landscape
Philips faces intense competition across its diverse business segments. Its strengths lie in its integrated healthcare solutions and consumer brand recognition. However, competitors like Siemens Healthineers and GE HealthCare are strong in diagnostic imaging and therapy, while ResMed is a dominant force in sleep and respiratory care. Philips' ability to navigate product recall issues and maintain innovation is critical for its competitive standing.
Major Acquisitions
Exeed
- Year: 2023
- Acquisition Price (USD millions):
- Strategic Rationale: Strengthening its capabilities in AI-driven diagnostics and medical imaging analysis.
Vision Sense
- Year: 2021
- Acquisition Price (USD millions): 85
- Strategic Rationale: To enhance its minimally invasive surgery portfolio with advanced visualization technology.
Growth Trajectory and Initiatives
Historical Growth: Philips has experienced periods of both robust growth and challenges, particularly influenced by its strategic transformations and product-related issues. Its shift towards healthcare has been a primary growth driver in recent years.
Future Projections: Analyst estimates for future growth are typically based on market trends, company guidance, and the successful resolution of ongoing challenges. Projections often focus on revenue growth in its healthcare segments and improvements in profitability.
Recent Initiatives: Recent initiatives include streamlining its organizational structure, focusing on profitable growth areas, investing in R&D for innovative healthcare solutions, and addressing the legacy issues related to its sleep and respiratory care business.
Summary
Koninklijke Philips NV ADR is a diversified health technology company with strong brand recognition and a broad product portfolio. Its core business areas in Personal Health, Connected Care, Diagnostic Imaging, and Image-Guided Therapy are well-positioned to capitalize on global health trends. However, the company has faced significant headwinds from product recalls, impacting its financial performance and market trust. Continued innovation, effective resolution of legacy issues, and strategic focus on integrated solutions will be crucial for its future strength and market recovery.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Koninklijke Philips N.V. Official Investor Relations Website
- SEC Filings (Form 20-F)
- Financial News Outlets (e.g., Bloomberg, Reuters)
- Market Research Reports (general industry data)
Disclaimers:
This JSON output is generated for informational purposes only and does not constitute financial advice. Market share data and financial figures are estimates and may vary based on reporting periods and methodologies. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Koninklijke Philips NV ADR
Exchange NYSE | Headquaters - | ||
IPO Launch date 1987-12-30 | President, CEO & Chairman of the Board of Management Mr. Roy Jakobs | ||
Sector Healthcare | Industry Medical Devices | Full time employees 67035 | Website https://www.philips.com |
Full time employees 67035 | Website https://www.philips.com | ||
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral CT solutions; ultrasound imaging solutions focused on diagnosis, treatment planning and guidance for cardiac, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional X-ray systems and software solutions; and interventional image devices and software to aid in the diagnosis, navigation, treatment, and confirmation in minimally invasive interventional coronary, peripheral vascular, and hearth rhythm management procedures. The company also offers acute patient management solutions; emergency care solutions; patient care management in ambulatory and home care; sleep and respiratory care solutions; and vendor-agnostic software solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental and women's health solutions; and grooming and beauty products and solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.